Jenny Wallis

Jenny Wallis is a seasoned professional in global program management with extensive experience in the pharmaceutical industry. Currently a Director at Takeda, Wallis leads global program teams for Hunter syndrome and other orphan and rare diseases, successfully navigating development challenges and minimizing delays in approval timelines after pivotal trial setbacks. Previous roles include Global Medical Affairs Project Manager at Roche and Global Program Team Director at Novartis, where Wallis demonstrated expertise in project management, risk management strategies, and resource planning. Earlier career experiences at Sandoz and Eli Lilly involved managing clinical trials and coordinating multinational studies. Wallis holds a PhD in Physiological Sciences from Newcastle University and a BSc(Hons) in Physiology from the University of Aberdeen.